Sodium Butyrate Induces Peri-Implantitis in Male Rats Via Caspase-3/ Gasdermin E Pathway Mediated Pyroptosis
Year: 2026
Type: article
Abstract: Introduction Peri-implantitis is a plaque-associated inflammatory disease characterized by progressive bone loss around implants, yet its underlying molecular mechanisms remain incompletely understood. Although butyric acid, a microbial metabolite enriched in peri-implant lesions, has been implicated in inflammatory tissue destruction, whether it contributes to peri-implantitis through Caspase-3/GSDME-mediated pyroptosis remains unclear. Methods (1) Peri-implant sulcular fluid was collected from healthy implants and peri-implantitis patients. Butyric acid and IL-1β were measured via gas chromatography-mass spectrometry and enzyme-linked immunosorbent assay. (2) Male rats received weekly peri-implant injections of 100 mM sodium butyrate (NaB), with or without the Caspase-3 inhibitor Ac-DEVD-CHO. Inflammation, bone loss, and pyroptosis-related marker expression were evaluated. Results Butyric acid and IL-1β were elevated in peri-implantitis patients and showed a moderate positive correlation (r = 0.6815, P < .05). NaB induced peri-implant inflammation and bone loss as demonstrated by radiographic and histological analyses (BV/TV P < .001; BMD P < .01) with increased Caspase-3 and Gasdermin E (GSDME) expression (immunohistochemical and molecular biological analysis; P < .01). Ac-DEVD-CHO treatment significantly reduced inflammatory cell infiltration, suppressed the expression of pyroptosis-related and osteoclastogenic markers, and attenuated bone loss, as demonstrated by radiographic, histological, and molecular biological analyses. Conclusion NaB exposure was associated with increased Caspase-3/GSDME pathway activation, peri-implant inflammation and bone loss. Caspase-3 inhibition alleviated these pathological changes, supporting this pathway as a potential therapeutic target for peri-implantitis. Clinical relevance Targeting the Caspase-3/GSDME pathway could provide a potential approach for managing peri-implantitis by reducing inflammation and bone loss, offering a possible complement to current treatment strategies.
Source: International Dental Journal
Institution: Peking University
Language: English
Subfield: Oral Surgery
Field: Dentistry
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,550
OpenAlex ID: W7236853378
